RxDoctor Payments DataLook up a doctor →

Lauren Bedrock, APRN

Family · Las Vegas, NVNPI 1093398190

Payments from drug & device makers

$9,396in general payments, 2019–2025

Across 522 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$899
  • GSK$743
  • Novo Nordisk$696
  • Boehringer Ingelheim$679
  • Pfizer$656
  • plus $5K from 44 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie68$1,020
AstraZeneca23$899
GSK44$743
Novo Nordisk35$696
Boehringer Ingelheim38$679
Pfizer43$656
Abbott27$607
Lilly USA, LLC59$550
Astellas Pharma US Inc22$451
Amgen(2 entities)19$356
Otsuka America Pharmaceutical, Inc.13$255
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC20$208
Novartis11$195
Lundbeck LLC10$168
Gilead8$166
Esperion Therapeutics, Inc.10$160
Biohaven Pharmaceutical Holding Company Ltd.7$132
Almatica Pharma LLC7$117
Johnson & Johnson1$112
Exact Sciences6$97
Orthofix Medical, Inc.1$90
Bayer5$83
Medtronic1$73
Phathom Pharmaceuticals, Inc.3$66
Lucid Diagnostics Inc.1$60
Axsome Therapeutics, Inc.3$55
Kaleo, Inc.3$55
Merck3$54
Takeda Pharmaceuticals U.S.A., Inc.3$53
Mylan Specialty L.p.2$41
Vanda Pharmaceuticals Inc.1$37
Harmony Biosciences LLC1$36
Dexcom, Inc.2$36
Shield Therapeutics Inc2$35
Ironwood Pharmaceuticals, Inc2$33
Idorsia Pharmaceuticals US Inc2$32
Nestle Healthcare Nutrition Inc.2$31
Halozyme Inc2$29
Viatris Specialty LLC1$28
Amarin Pharma, Inc.1$24
Aimmune Therapeutics, Inc.1$22
Impel Pharmaceuticals Inc.1$21
Verona Pharma, Inc.1$20
IBSA Pharma Inc.1$19
Sunovion Pharmaceuticals Inc.1$19
Corcept Therapeutics1$18
Mannkind Corporation1$16
Averitas Pharma Inc.1$15
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Kowa Pharmaceuticals America, Inc.1$14

How this compares

$9,396 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada →

Medicare billing

Part B allowed, 2024
$39,445
Medicare patients
139
Services billed
587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →